stock
Arbutus Biopharma Corp
NASDAQ | ABUS
3.30
USD
-0.02 (-0.60%)
AT CLOSE (AS OF Mar 14, 2025)
$625M
MARKET CAP
-
P/E Ratio
-0.43
EPS
$4.7
52 Week High
$2.3
52 Week Low
LIFE SCIENCES
Sector
Profile
Arbutus Biopharma Corp Profile
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Arbutus Biopharma Corporation, a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of a cure for patients with chronic hepatitis B virus (HBV) infection in the United States. The company is headquartered in Warminster, Pennsylvania.
Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.